1. Aminizadeh S, Habibi A, Masoumi-Ardakani Y, Shahouzehi B, Marefati H, Shakerian S. The role of estrogen-related receptor α (ERRα) in metabolic adaptations by endurance training in skeletal muscle of streptozotocin-induced diabetic rats. Sport Sciences for Health 2021; 17: 585-596. [
DOI:10.1007/s11332-020-00714-7]
2. Askaripour M, Najafipour H, Saberi S, Jafari E, Rajabi S. Daidzein mitigates oxidative stress and inflammation in the injured kidney of ovariectomized rats: AT1 and Mas receptor functions. Iranian Journal of Kidney Diseases 2022a; 16: 32-43.
3. Askaripour M, Najafipour H, Saberi S, Yazdani S, Jafarinejad-Farsangi S, Rajabi S, et al. Isoflavone daidzein ameliorates renal dysfunction and fibrosis in a postmenopausal rat model: Intermediation of angiotensin AT1 and Mas receptors and microRNAs 33a and 27a. Iranian Journal of Basic Medical Sciences 2022b; 25: 1317-1325.
4. Castaneda C, Gordon P L, Parker R C, Uhlin K L, Roubenoff R, Levey A S. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. American Journal of Kidney Diseases 2004; 43: 607-616. [
DOI:10.1053/j.ajkd.2003.12.025]
5. Chacko B K, Srivastava A, Johnson M S, Benavides G A, Chang M J, Ye Y, et al. Mitochondria-targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis. Hepatology 2011; 54: 153-163. [
DOI:10.1002/hep.24377]
6. Cheema B S. Review article: Tackling the survival issue in end-stage renal disease: time to get physical on haemodialysis. Nephrology (Carlton) 2008; 13: 560-569. [
DOI:10.1111/j.1440-1797.2008.01036.x]
7. Chevalier R L, Forbes M S, Thornhill B A. Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney International 2009; 75: 1145-1152. [
DOI:10.1038/ki.2009.86]
8. Dendooven A, Ishola D A, Jr., Nguyen T Q, Van der Giezen D M, Kok R J, Goldschmeding R, et al. Oxidative stress in obstructive nephropathy. International Journal of Experimental Pathology 2011; 92: 202-210. [
DOI:10.1111/j.1365-2613.2010.00730.x]
9. Escribano-Lopez I, Diaz-Morales N, Rovira-Llopis S, de Marañon A M, Orden S, Alvarez A, et al. The mitochondria-targeted antioxidant MitoQ modulates oxidative stress, inflammation and leukocyte-endothelium interactions in leukocytes isolated from type 2 diabetic patients. Redox Biology 2016; 10: 200-205. [
DOI:10.1016/j.redox.2016.10.017]
10. Graham D, Huynh N N, Hamilton C A, Beattie E, Smith R A, Cochemé H M, et al. Mitochondria-targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 2009; 54: 322-328. [
DOI:10.1161/HYPERTENSIONAHA.109.130351]
11. Gu Q, Zhao L, Ma Y P, Liu J D. Contribution of mitochondrial function to exercise-induced attenuation of renal dysfunction in spontaneously hypertensive rats. Molecular and Cellular Biochemistry 2015; 406: 217-225. [
DOI:10.1007/s11010-015-2439-6]
12. Hammad F T, Lubbad L, Al-Salam S, Yasin J, Meeran M F N, Ojha S, et al. The effect of hypertension on the recovery of renal dysfunction following reversal of unilateral ureteral obstruction in the rat. International Journal of Molecular Sciences 2023; 24. [
DOI:10.3390/ijms24087365]
13. Hassan N M E, Said E, Shehatou G S G. Nifuroxazide suppresses UUO-induced renal fibrosis in rats via inhibiting STAT-3/NF-κB signaling, oxidative stress and inflammation. Life Sciences 2021; 272: 119241. [
DOI:10.1016/j.lfs.2021.119241]
14. Huang T, Shen J, Bao B, Hu W, Sun Y, Zhu T, et al. Mitochondrial-targeting antioxidant MitoQ modulates angiogenesis and promotes functional recovery after spinal cord injury. Brain Research 2022; 1786: 147902. [
DOI:10.1016/j.brainres.2022.147902]
15. Jeong J H, Koo J H, Yook J S, Cho J Y, Kang E B. Neuroprotective benefits of exercise and mitoQ on memory function, mitochondrial dynamics, oxidative stress, and neuroinflammation in D-galactose-induced aging rats. Brain Sciences 2021; 11. [
DOI:10.3390/brainsci11020164]
16. Kelso G F, Porteous C M, Coulter C V, Hughes G, Porteous W K, Ledgerwood E C, et al. Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. Journal of Biological Chemistry 2001; 276: 4588-4596. [
DOI:10.1074/jbc.M009093200]
17. Klahr S, Pukerson M L. The pathophysiology of obstructive nephropathy: the role of vasoactive compounds in the hemodynamic and structural abnormalities of the obstructed kidney. American Journal of Kidney Diseases 1994; 23: 219-223. [
DOI:10.1016/S0272-6386(12)80975-9]
18. Li Q, Li K, Chen Z, Zhou B. Anti-renal fibrosis and anti-inflammation effect of urolithin B, ellagitannin-gut microbial-derived metabolites in unilateral ureteral obstruction rats. Journal of Functional Foods 2020; 65: 103748. [
DOI:10.1016/j.jff.2019.103748]
19. Lønbro S, Wiggins J M, Wittenborn T, Elming P B, Rice L, Pampo C, et al. Reliability of blood lactate as a measure of exercise intensity in different strains of mice during forced treadmill running. PLoS One 2019; 14: e0215584. [
DOI:10.1371/journal.pone.0215584]
20. Martínez-Klimova E, Aparicio-Trejo O E, Gómez-Sierra T, Jiménez-Uribe A P, Bellido B, Pedraza-Chaverri J. Mitochondrial dysfunction and endoplasmic reticulum stress in the promotion of fibrosis in obstructive nephropathy induced by unilateral ureteral obstruction. Biofactors 2020; 46: 716-733. [
DOI:10.1002/biof.1673]
21. Martínez-Klimova E, Aparicio-Trejo O E, Tapia E, Pedraza-Chaverri J. Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments. Biomolecules 2019; 9. [
DOI:10.3390/biom9040141]
22. Masoumi-Ardakani Y, Najafipour H, Nasri H R, Aminizadeh S, Jafari S, Moflehi D. Effect of combined endurance training and MitoQ on cardiac function and serum level of antioxidants, NO, miR-126, and miR-27a in hypertensive individuals. BioMed Research International 2022a; 2022: 8720661. [
DOI:10.1155/2022/8720661]
23. Masoumi-Ardakani Y, Najafipour H, Nasri H R, Aminizadeh S, Jafari S, Safi Z. Moderate endurance training and MitoQ improve cardiovascular function, oxidative stress, and inflammation in hypertensive individuals: the role of miR-21 and miR-222: a randomized, double-blind, clinical trial. Cell Journal 2022b; 24: 577-585.
24. Melo L, Bilici M, Hagar A, Klaunig J E. The effect of endurance training on non-alcoholic fatty liver disease in mice. Physiological Reports 2021; 9: e14926. [
DOI:10.14814/phy2.14926]
25. Pei G, Tang Y, Tan L, Tan J, Ge L, Qin W. Aerobic exercise in adults with chronic kidney disease (CKD): a meta-analysis. International Urology and Nephrology 2019; 51: 1787-1795. [
DOI:10.1007/s11255-019-02234-x]
26. Racusen L C, Solez K, Colvin R B, Bonsib S M, Castro M C, Cavallo T, et al. The Banff 97 working classification of renal allograft pathology. Kidney International 1999; 55: 713-723. [
DOI:10.1046/j.1523-1755.1999.00299.x]
27. Rao B, Soufir J C, Martin M, David G. Lipid peroxidation in human spermatozoa as related to midpiece abnormalities and motility. Gamete Research 1989; 24: 127-134. [
DOI:10.1002/mrd.1120240202]
28. Roshan V D, Assali M, Moghaddam A H, Hosseinzadeh M, Myers J. Exercise training and antioxidants: effects on rat heart tissue exposed to lead acetate. International Journal of Toxicology 2011; 30: 190-196. [
DOI:10.1177/1091581810392809]
29. Rostamzadeh F, Najafipour H, Aminizadeh S, Jafari E. Therapeutic effects of the combination of moderate-intensity endurance training and MitoQ supplementation in rats with isoproterenol-induced myocardial injury: The role of mitochondrial fusion, fission, and mitophagy. Biomed Pharmacother 2024; 170: 116020. [
DOI:10.1016/j.biopha.2023.116020]
30. Smith R A, Murphy M P. Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Annals of the New York Academy of Sciences 2010; 1201: 96-103. [
DOI:10.1111/j.1749-6632.2010.05627.x]
31. So B, Park J, Jang J, Lim W, Imdad S, Kang C. Effect of aerobic exercise on oxidative stress and inflammatory response during particulate matter exposure in mouse lungs. Front Physiol 2021; 12: 773539. [
DOI:10.3389/fphys.2021.773539]
32. Srivastava A, Tomar B, Sharma D, Rath S K. Mitochondrial dysfunction and oxidative stress: Role in chronic kidney disease. Life Sciences 2023; 319: 121432. [
DOI:10.1016/j.lfs.2023.121432]
33. Stump C S. Physical activity in the prevention of chronic kidney disease. Cardiorenal Medicine 2011; 1: 164-173. [
DOI:10.1159/000329929]
34. Xiao L, Xu X, Zhang F, Wang M, Xu Y, Tang D, et al. The mitochondria-targeted antioxidant MitoQ ameliorated tubular injury mediated by mitophagy in diabetic kidney disease via Nrf2/PINK1. Redox Biology 2017; 11: 297-311. [
DOI:10.1016/j.redox.2016.12.022]
35. Zadeh H J, Roholamini Z, Aminizadeh S, Deh-Ahmadi M A. Endurance training and MitoQ supplementation improve spatial memory, VEGF expression, and neurogenic factors in hippocampal tissue of rats. Journal of Clinical and Translational Research 2023; 9: 1-7. [
DOI:10.18053/jctres.09.202301.001]
36. Zoladz J A, Koziel A, Woyda-Ploszczyca A, Celichowski J, Jarmuszkiewicz W. Endurance training increases the efficiency of rat skeletal muscle mitochondria. Pflugers Archiv 2016; 468: 1709-1724. [
DOI:10.1007/s00424-016-1867-9]